TY - JOUR
T1 - An Official ATS/ERS/JRS/ALAT Statement
T2 - Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management
AU - Raghu, Ganesh
AU - Collard, Harold R.
AU - Egan, Jim J.
AU - Martinez, Fernando J.
AU - Behr, Juergen
AU - Brown, Kevin K.
AU - Colby, Thomas V.
AU - Cordier, Jean François
AU - Flaherty, Kevin R.
AU - Lasky, Joseph A.
AU - Lynch, David A.
AU - Ryu, Jay H.
AU - Swigris, Jeffrey J.
AU - Wells, Athol U.
AU - Ancochea, Julio
AU - Bouros, Demosthenes
AU - Carvalho, Carlos
AU - Costabel, Ulrich
AU - Ebina, Masahito
AU - Hansell, David M.
AU - Johkoh, Takeshi
AU - Kim, Dong Soon
AU - King, Talmadge E.
AU - Kondoh, Yasuhiro
AU - Myers, Jeffrey
AU - Müller, Nestor L.
AU - Nicholson, Andrew G.
AU - Richeldi, Luca
AU - Selman, Moisés
AU - Dudden, Rosalind F.
AU - Griss, Barbara S.
AU - Protzko, Shandra L.
AU - Schünemann, Holger J.
PY - 2011/3/15
Y1 - 2011/3/15
N2 - This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sectionsondefinitionandepidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a questionbased format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
AB - This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sectionsondefinitionandepidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a questionbased format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
KW - Diagnosis
KW - Evidence-based medicine
KW - Idiopathic pulmonary fibrosis
KW - Therapeutics
KW - Usual interstitial pneumonia
UR - http://www.scopus.com/inward/record.url?scp=79952717349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952717349&partnerID=8YFLogxK
U2 - 10.1164/rccm.2009-040GL
DO - 10.1164/rccm.2009-040GL
M3 - Article
C2 - 21471066
AN - SCOPUS:79952717349
SN - 1073-449X
VL - 183
SP - 788
EP - 824
JO - American journal of respiratory and critical care medicine
JF - American journal of respiratory and critical care medicine
IS - 6
ER -